Two doses of a lipid formulation of amphotericin B for the treatment of Mediterranean visceral leishmaniasis.

Abstract

To evaluate the efficacy of a short course of a lipid formulation of amphotericin B (L-AmB) for the treatment of Mediterranean visceral leishmaniasis (VL), an open prospective study was conducted. Forty-one children with parasitologically confirmed leishmaniasis received L-AmB, 10 mg/kg daily for 2 days. The comparison groups were 30 children who, in a… (More)

Topics

  • Presentations referencing similar topics